BA3182 for Advanced Adenocarcinoma
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Recruiting
Phase 1
Interventional Study
Advanced Adenocarcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 168 (estimated)
- Sponsor
- BioAtla, Inc. · Industry
Who this trial is looking for
This trial is looking for adults with advanced adenocarcinoma. Participants will receive the treatment BA3182 to help assess its safety and effectiveness.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old.
- I have been diagnosed with advanced adenocarcinoma.
- I have good kidney function.
- I have good liver function.
- I have good blood health.
- My ECOG performance status is 0 or 1.
You may not be able to join if
- I have serious heart disease.
- I have uncontrolled brain metastasis.
- I have an active autoimmune disease.
- I have had severe allergic reactions to similar therapies.
- I have not fully recovered from major surgery or a serious injury.
- I am HIV positive or have active hepatitis B or C.
- I am pregnant or breastfeeding.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Histologically or cytologically confirmed locally advanced unresectable or metastatic adenocarcinoma
* Age ≥ 18 years
* Adequate renal function
* Adequate liver function
* Adequate hematological function
* Have an Eastern Cooperative Oncology Group (ECOG) performance status of…
Contacts